Brings background in data, AI, and analytics to help guide research collaboration and improved patient outcomes WASHINGTON, April 15, 2024 — GO2 for Lung Cancer (GO2) announced that the organization elected Fern Halper, Ph.D. to its board of directors. Halper is [...]
Congratulations to our 2024 Lung Cancer Support Group Facilitator award recipient, Christine Conti, from Huntington Health in Pasadena, California. This award, given annually since 2009, recognizes the uncommon dedication of support group facilitators. Christine Conti, RN, ONN-CG, is a thoracic [...]
On March 1, 2024, the U.S. Food and Drug Administration (FDA) approved the drug Rybrevant (amivantamab-vmjw) to be given in combination with carboplatin and pemetrexed in the first lining setting for people with metastatic non-small cell lung cancer (NSCLC) with [...]
More than 230,000 Americans will die of lung cancer this year WASHINGTON, March 4, 2024 - On Tuesday, March 5 GO2 for Lung Cancer (GO2) will host more than 200 supporters on Capitol Hill to educate members of Congress on the [...]
On Feb. 15, 2024, the U.S. Food and Drug Administration (FDA) granted traditional approval of Tepmetko (tepotinib) for people living with metastatic non-small cell lung cancer (NSCLC) with a MET-Exon 14 mutation. Tepmetko (tepotinib) initially received accelerated approval in [...]
WASHINGTON, Feb. 16, 2023—GO2 for Lung Cancer President and CEO Laurie Ambrose submitted testimony to the House Committee on Energy and Commerce, Subcommittee on Health. Ambrose’s testimony was in support of the Women and Lung Cancer Research & Preventive [...]
Granville brings experience overseeing scientific strategy and research WASHINGTON, Feb. 12, 2024 — GO2 for Lung Cancer (GO2) announced that it has hired Courtney Granville as chief scientific officer. In this role, she oversees GO2’s community-engaged research, clinical research, Lung Cancer [...]
GO2 for Lung Cancer joined a diverse group of women’s health champions by signing two letters sent to First Lady Jill Biden, who leads the White House Initiative on Women’s Health Research. The letters offer insights and recommendations on [...]
SAN CARLOS, Calif. and WASHINGTON (November 13, 2023) – GO2 for Lung Cancer (GO2) honored champions of lung cancer at its 18th Annual Simply the Best Gala held in San Francisco on November 11. This special evening was an opportunity to recognize [...]
GO2 for Lung Cancer announced that researchers have described a new familial syndrome in people with lung cancer caused by an inherited gene mutation. The research study was published this month in the Journal of Clinical Oncology. The report chronicles [...]